A dispute over a bylaw ruling in Pelham, Ontario with a Canadian licensed producer (LP) gets resolved, leading to a stock jump for the company.

After a ruling had left CannTrust Holdings (TSX:TRST) scrambling to find a solution for its expansion plans in Pelham, the cannabis firm announced on Tuesday (January 22) it had obtained the “necessary permitting” from the municipality.


However, the approval from Pelham comes with a reduced size in facility footprint.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

The planned phase 3 expansion caught up in the bylaw’s effects was projected to bring the company up to a 100,000 kilograms sum of cannabis production per year.

CannTrust indicated the approval from Pelham is for a footprint of up to 390,000 square feet instead of the originally planned 600,000 square feet.

The company argues it will perform enhancements to the phase 3 expansion and continues to expect a capacity forecast of 100,000 kilograms per year.

“We believe this decision reflects our view that we are a trusted member of the community and that we are intent on listening to our stakeholders,” Peter Aceto, CEO of CannTrust said in a statement to investors.

CannTrust expects to complete the phase 3 expansion by the third quarter of 2020, while a full production capacity will be reached in the second half of 2020.

Shares of CannTrust bounced on Tuesday’s trading session following the critical resolution for the company. As of 1:52 P.M. EST the company was up 2.56 percent in Toronto. By market close, shares of CannTrust had dipped back downt o C$9.12, representing a 1.67 percent increase over the trading period.

This confirmation for CannTrust comes on the heels of Aceto telling the Financial Post the company was “urgently” scheduling talks with Pelham to plead its case.

Pelham leaves CannTrust answering questions from investors and analysts

CannTrust was left scrambling in October after the city council for the Town of Pelham passed a bylaw to monitor the use of land in the city, therefore restricting the company’s planned a 600,000-square-foot expansion.

“The most prudent thing to do at this time is take a bit of a pause and work together to solve these issues,” Pelham mayor Dave Augustyn said at the time of the bylaw getting approved.

In an interview with the online show Midas Letter, Aceto said that expansion, would have been approved had it been combined with its existing facility, since the proposed expansion is adjacent to its land in use.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

In a note to clients issued in January, Bank of Montreal (TSX:BMO) analysts Peter Sklar and Tamy Chen issued a warning to CannTrust and its ability to secure its projected production targets.

“We consider this to be a potential negative development, as a delay in CannTrust’s ramp to full production will limit its ability to capitalize on the near-term under-supplied Canadian market,” the analysts wrote.

Investor takeaway

With this confirmation CannTrust is able to clear up the mounting questions from investors on its expansion plans.

The company is close to finishing a phase 2 expansion which will make it reach 50,000 kilograms of production per year.

Update

Aceto addressed the update from Pelham during the Canaccord Genuity Group (TSX:CF) “Growth Investor Day” in Vancouver on Tuesday.

The executive said after its private meeting with Pelham both parties came to an understanding.

He said the main concerns raised by the community for all cannabis operations in their community were the increase in density with significant car movement and the smell from the cannabis operations.

However, Aceto said these issues weren’t exclusive to CannTrust’s expansion. He conceded CannTrust’s facility had caused disruption with its lighting.

“In order to address local concerns from the emission of light from its facilities, CannTrust is proceeding to add additional fan ventilation so its shades can be completely closed, at minimal incremental cost,” the LP notified to investors.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

HempFusion Wellness Inc . (TSX:CBD.U) (US:CBDHF) (FWB:8OO) (“ HempFusion ” or the “ Company ”), a leading health and wellness company offering premium probiotic supplements and products containing CBD, announced today it will report its financial results for the first quarter ended March 31, 2021 at 4 p.m., Eastern Time, on Monday, May 17, 2021 followed by a 4:15 p.m., Eastern Time conference call and webcast with a question-and-answer session.

To participate in the call, please dial 888-506-0062. For international callers, dial 973-528-0011. Use Participant Code: 795055

Keep reading... Show less

Partnership Aimed at Delivering Psychedelic
Capsule for Dosing Study in Human Clinical Trial

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, and Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, have met another early milestone in the development of an initial all natural psilocybin extract.

Keep reading... Show less

Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, and Numinus Wellness Inc. (“Numinus“) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, have met another early milestone in the development of an initial all natural psilocybin extract.

Optimi and Numinus, through Impact Clinical Trials Accelerator at the University of Calgary (“Impact”), have submitted a pre-clinical trial application to Health Canada for review and comment. Meanwhile, cultivation, research, formulation, and continuous validation studies to produce the investigational psilocybin extract for trial continue at the Health Canada-licensed Numinus lab in British Columbia, Canada.

Keep reading... Show less

Poised for Rapid Growth in Europe’s Largest Medical Cannabis Market

Curaleaf Holdings, Inc. (CSE: CURA OTCQX: CURLF) (“Curaleaf” or the “Company”) a leading international provider of consumer products in cannabis, today announced that wholly owned Curaleaf International subsidiary Adven GmbH (“Adven”) has launched its own range of medical cannabis products in Germany Europe’s largest medical cannabis market.  The initial launch of a high THC oil product aims to meet immediate patient demand and will be extended over the course of the year to incorporate a number of different strengths and THCCBD formulations in both oil and flower formats, addressing a wide range of patient needs. Germany is Europe’s largest medical cannabis market and is expected to be worth US$2.1 billion by 2025 1 .

Keep reading... Show less

After announcing placements of Fit Soda™ in well-known regional grocery chains such as HEB and Sprouts, Koios is pleased to announce that its Fit Soda™ functional beverage is now available in all Food Lion supermarkets, a chain which operates more than 1,100 grocery stores in the eastern United States. As the sugar-free beverage category continues to grow, Coca-Cola recently announced its prediction that its “Coke Zero Sugar” variety will be the firm’s biggest driver of growth in 2021 and beyond. Based on these industry trends, Koios’ objective is to strategically grow the market presence of Fit Soda™, which sold approximately 700,000 units in 2020, its first full calendar year on the market.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that as of Monday, May 10, 2021 all four flavours of Fit Soda ™ are being carried in more than 1,100 supermarkets operated by Food Lion LLC (“Food Lion”), a multistate grocery chain based in Salisbury, North Carolina. Since November 2020, the Company has placed its Fit Soda ™ functional beverage product with several other regional chains across the United States to include HEB (as announced in a November 4, 2020 press release), all three banners of Massachusetts-based Roche Bros. (as announced in a February 24, 2021 press release), and Sprouts Farmers Market (as announced in a March 4, 2021 press release). Approximately 700,000 units of Fit Soda ™ were sold during the product’s first full calendar year of retail sales in 2020 between retail placements in grocery and foodservice outlets, as well as direct-to-consumer sales through the Koios online store. With the addition of Fit Soda ™ to all 1,100 locations of Food Lion across ten U.S. states, the Company believes there is significant opportunity for Fit Soda ™ to have its best year yet in 2021.

Keep reading... Show less